Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

about

Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases-An Overview of Imaging Studies.Quantitative study of F-(+)DTBZ image: comparison of PET template-based and MRI based image analysis

P2860

Q49987358-FCBAA687-84FA-4B90-AA8C-092426B3A9FC Q55004525-2C2035D7-D04E-4F57-B04A-359FB0785E7E Q58099045-107F06D7-7CEC-4B2B-9EF9-5BA15E5746BF

P2860

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

Item

http://www.wikidata.org/entity/Q47373845

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

@en

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

@nl

type

Item

label

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

@en

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

@nl

prefLabel

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

@en

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

@nl

P1476

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

@en

P2093

Tero Vahlberg

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

Ageing and Parkinson's disease: substantia nigra regional selectivity

In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment.

No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease.

Gender differences in Parkinson's disease: clinical characteristics and cognition

The nature of progression in Parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling.

Changes in network activity with the progression of Parkinson's disease.

Kinetics of neurodegeneration based on a risk-related biomarker in animal model of glaucoma.

P304

873-882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1002/ANA.25103

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Valtteri Kaasinen

Tero Vahlberg

P577

2017-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29165839

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

corpus striatum

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

about

P2860

P2860

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921